logo
Select company
Select metric
$ 3.73MNet Cash Flow - Financing
VS
Market
40
Sector
56
Industry
66
History
85
$ 2Close
$ 0.54 - $ 3.91 52-Week Range
Ticker Information

Ticker

PALI

Company Name

PALISADE BIO INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PALISADE BIO INC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PALI - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ 3.73M
3/31/2025$ 7.3M
12/31/2024$ 9.58M
9/30/2024$ 5.29M
6/30/2024$ 7.04M
3/31/2024$ 8.77M
12/31/2023$ 11.19M
9/30/2023$ 13.03M
6/30/2023$ 23.51M
3/31/2023$ 19.79M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PALISADE BIO INC's latest trailing twelve months (TTM) CF - Financing stands at $ 14.33M.
  • Over the past 5 years, PALISADE BIO INC's average CF - Financing has been $ 13.73M.
  • The median CF - Financing for PALISADE BIO INC during this period was $ 13.01M
  • PALISADE BIO INC reached its highest CF - Financing over the past 5 years at $ 25.16M.
  • The lowest CF - Financing recorded by PALISADE BIO INC in the same timeframe $ 3.73M

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

PALI - Net Cash Flow - Financing, Last 5 years

$ 3.73M

Minimum

Jun 30, 2025

$ 25.16M

Maximum

Sep 30, 2021

$ 13.73M

Average

$ 13.01M

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.84M with a standard deviation of $ 119.27M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.22K
min$ -367.1M
max$ 366M
average$ -6.84M
median$ 305K
std$ 119.27M